Maksay G
Department of Molecular Pharmacology, Hungarian Academy of Sciences, Budapest.
Eur J Pharmacol. 1992 Sep 1;227(1):57-62. doi: 10.1016/0922-4106(92)90142-i.
The effect of selective protein modifying reagents was examined on benzodiazepine (BZ) receptors in synaptosomal membrane preparations of rat whole brain and cerebellum. The potency of diethyl pyrocarbonate, a histidine modifying reagent, to inactivate BZ receptor binding, correlated with the rank order of agonist-inverse agonist efficacies of BZ ligands, the binding of the partial inverse agonist [3H]Ro 15-4513 was inactivated least. Diethyl pyrocarbonate slightly enhanced the displacing potency of Ro 15-4513 and enhanced its binding in low concentrations (1-2 mM). Diazepam-sensitive and -insensitive components of [3H]Ro 15-4513 binding were separated in cerebellum. Diethyl pyrocarbonate inactivated the diazepam-sensitive component with a potency (IC50 = 1.8 mM) similar to that on the binding of other benzodiazepines, while the diazepam-insensitive component was resistant to diethyl pyrocarbonate. Tetranitromethane and 2,3-butanedione (diacetyl), reagents specific for tyrosine and arginine residues respectively, exerted concentration-dependent partial inactivation of [3H]Ro 15-4513 binding. The diazepam-insensitive component of cerebellar Ro 15-4513 binding was more sensitive to inactivation by diacetyl but less sensitive to inactivation by tetranitromethane. These findings are consistent with a distinctive role of histidine-101 in alpha 1, alpha 2, alpha 3 and alpha 5 subunits of the gamma-aminobutyric acidA receptor complex and the His is replaced by an arginine residue in the alpha 6 subunit of the diazepam-insensitive cerebellar benzodiazepine receptors. The only other point of the protein sequence where histidine residues conserved in alpha 1, alpha 2, alpha 3 and alpha 5 subunits are replaced in alpha 6 is tyrosine-214 but this residue does not appear to contribute to benzodiazepine binding.
在大鼠全脑和小脑的突触体膜制剂中,研究了选择性蛋白质修饰试剂对苯二氮䓬(BZ)受体的影响。组氨酸修饰试剂焦碳酸二乙酯使BZ受体结合失活的效力,与BZ配体的激动剂-反向激动剂效力的排序相关,部分反向激动剂[3H]Ro 15-4513的结合失活最少。焦碳酸二乙酯略微增强了Ro 15-4513的置换效力,并在低浓度(1-2 mM)下增强了其结合。在小脑中分离出了[3H]Ro 15-4513结合的地西泮敏感和不敏感成分。焦碳酸二乙酯使地西泮敏感成分失活的效力(IC50 = 1.8 mM)与对其他苯二氮䓬结合的效力相似,而地西泮不敏感成分对焦碳酸二乙酯有抗性。四硝基甲烷和2,3-丁二酮(二乙酰)分别是酪氨酸和精氨酸残基的特异性试剂,它们对[3H]Ro 15-4513结合产生浓度依赖性的部分失活作用。小脑Ro 15-4513结合的地西泮不敏感成分对二乙酰失活更敏感,但对四硝基甲烷失活较不敏感。这些发现与组氨酸-101在γ-氨基丁酸A受体复合物的α1、α2、α3和α5亚基中具有独特作用一致,并且在对苯二氮䓬不敏感的小脑苯二氮䓬受体的α6亚基中,组氨酸被精氨酸残基取代。蛋白质序列中另一个唯一的点是,在α1、α2、α3和α5亚基中保守的组氨酸残基在α6中被酪氨酸-214取代,但该残基似乎对苯二氮䓬结合没有贡献。